Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Surgery Helps With Prostate Cancer, Sometimes

New study fails to settle question about best treatment for the disease

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Ankylosing Spondylitis
Baldness
Basal Cell Carcinoma
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Cialis
Epogen
Flomax
Iressa
More...

Related News Articles
 border=
Transfusing Anemic Cancer Patients Boosts Clot Risk
The Ups and Downs of Alcohol
A New Way to Stop Cancer?
Women Smokers Lose 14.5 Years Off Life Span
More...

TUESDAY, Aug. 12 (HealthDay News) -- The latest update from a European study that has followed men with prostate cancer for more than a decade leaves the debate about the advantages of aggressive treatment versus "watchful waiting" undecided.

The advantage in survival seen for men who underwent surgery to remove the prostate disappeared after 10 years. While deaths attributed to cancer continued to be lower among those having surgery, the overall death rate for both groups was the same, according to the researchers with the Scandinavian Prostate Cancer Group.

Text Continues Below



The meaning of the study for men now being diagnosed with prostate cancer is uncertain, because the study began before the use of testing for prostate-specific antigen, today's primary method of diagnosis, the researchers added.

"In settings with a large proportion of PSA-detected tumors, the relative reduction in risk of death following radical prostatectomy [removal of the gland] might be somewhat larger or similar to that in our study, but the absolute reduction would be smaller," they wrote.

The findings were published online Aug. 12 in the Journal of the National Cancer Institute.

Dr. Yu-Ning Wong, an oncologist at the Fox Chase Cancer Center in Philadelphia, said it's "unclear how these results apply to the patients we are taking care of today. They show how many questions remain unanswered."

Wong led a study that found an apparent benefit in survival for men who had aggressive surgical treatment of early prostate cancer. But it wasn't a randomized, controlled trial -- the gold standard for medical research.

"Basically, I don't think we know the right answer about what to do," she said.

Prostate cancer is diagnosed in about one of every six American men. There's currently no way to distinguish between a cancer that will grow so slowly that it poses little danger to life from one that can grow aggressively enough to be fatal. A common medical saying is that "more men die with their prostate cancer than of it."

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 8/12/2008

Related Links
 border=
From Healthscout's partner site on prostate, ProstateCommons.com
Prostate Check: Test yourself for symptoms online
Video: Prostate ultrasounds may save lives
Treatment: Get information about enlarged prostate treatments





SOURCES: Yu-Ning Wong, M.D., oncologist, Fox Chase Cancer Center, Philadelphia; Stephen Zeliadt, Ph.D., affiliate investigator, Fred Hutchinson Cancer Research Center, Seattle; Peter T. Scardino, M.D., chairman, department of surgery, Memorial Sloan-Kettering Cancer Center, New York City; Aug. 12, 2008, Journal of the National Cancer Institute, online


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map